UTHR Kronos AI forecast
A 30-trading-day price forecast for United Therapeutics Corporation (UTHR) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts United Therapeutics Corporation at $523.63 on 2026-12-08, −11.4% from the last close of $591.20 on 2026-10-27. Eight out of ten sampled paths end between $516.31 and $540.39, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of UTHR
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $586.19 | $574.36 | $593.47 |
| 2026-11-10 | $567.19 | $558.79 | $575.66 |
| 2026-11-17 | $541.02 | $512.47 | $557.21 |
| 2026-11-24 | $537.85 | $520.28 | $546.23 |
| 2026-12-01 | $529.32 | $522.08 | $535.90 |
| 2026-12-08 | $523.63 | $516.31 | $540.39 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for UTHR?
- Kronos AI's median forecast for UTHR is $523.63 in 30 trading days, −11.4% from the last close, with a 10–90% range of $516.31 to $540.39.
- Is the UTHR Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC